The Centers for Disease Control and Prevention is one step closer to recommending the RSV vaccine for adults 65 years and older. The agency's vaccine advisory committee voted 9-2 this week in favor of ...

The Food and Drug Administration on Wednesday approved the world’s first RSV vaccine: a shot for adults ages 60 and up, made by pharmaceutical giant GSK. The milestone was decades in the making.

The season of never-ending sneezing and stuffy noses is underway, sending Americans to pharmacy lines in hopes of keeping illness at bay with yearly shots. While flu and COVID-19 vaccines are an ...

A study of nursing home residents demonstrated that vaccination against respiratory syncytial virus reduced their risk for ...

RSV is a common virus that infects the lungs. While symptoms are mild for many people, the virus can be severe in older adults, causing pneumonia, bronchitis and flare-ups of existing lung disease and ...

Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing the largest share of media coverage and public attention. But it is also the ...

In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection1* GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has ...

Respiratory tract infections continue to impose a substantial global disease burden, with lower respiratory tract infections remaining the leading cause of death worldwide. According to 2021 data from ...